# ARSG

## Overview
The ARSG gene encodes the enzyme arylsulfatase G, a lysosomal sulfatase involved in the degradation of sulfate esters, which are crucial for cellular metabolism and function. This enzyme is categorized as a lysosomal enzyme and plays a significant role in the catabolism of heparan sulfate, a glycosaminoglycan, by removing specific sulfate groups from its structure (Kowalewski2012Arylsulfatase; Khateb2018A). The ARSG protein is characterized by its sequence similarity to other sulfatases and undergoes post-translational modifications, including glycosylation, which are essential for its maturation and function (Ferrante2002Molecular). Mutations in the ARSG gene have been linked to Usher syndrome type IV, a condition marked by progressive sensorineural hearing loss and retinitis pigmentosa, highlighting the clinical significance of this gene in human health (Velde2022Usher).

## Structure
The ARSG (arylsulfatase G) protein is a lysosomal enzyme encoded by the ARSG gene. It consists of 525 amino acids and shares significant sequence similarity with other sulfatases, particularly arylsulfatase A, with 37% identity and 50% similarity (Ferrante2002Molecular). The protein undergoes glycosylation, maturing from a 62 kDa precursor to a 70 kDa form, indicating the presence of post-translational modifications. Specifically, ARSG has four putative N-glycosylation sites at asparagine residues 117, 215, 356, and 497, which are utilized as evidenced by a reduction in molecular size upon treatment with endoglycosidase H and F (Ferrante2002Molecular).

The ARSG protein's active site includes a critical aspartate residue at position 45, essential for coordinating a calcium ion next to the catalytic formylglycine residue, crucial for its enzymatic activity (Khateb2018A). Mutations in this region, such as the p.D45Y variant, disrupt enzymatic function by preventing the formation of the FGly-sulfate ester, an essential intermediate in the catalytic cycle (Khateb2018A). Despite these insights, detailed information on the primary, secondary, tertiary, or quaternary structures, specific domains, or prominent folds of ARSG is not provided in the available context.

## Function
The ARSG gene encodes the enzyme arylsulfatase G, which is a lysosomal sulfatase involved in the breakdown of sulfate esters, a critical process for cellular metabolism and function (Khateb2018A). In healthy human cells, ARSG plays a vital role in the catabolism of heparan sulfate, a type of glycosaminoglycan (GAG). It specifically removes the 3-O-sulfate group from N-sulfoglucosamine-3-O-sulfate (GlcNS3S) residues at the non-reducing ends of heparan sulfate chains (Kowalewski2012Arylsulfatase). This enzymatic activity is essential for the complete degradation of heparan sulfate, preventing its accumulation in cells, which can lead to mucopolysaccharidosis (MPS) disorders if disrupted (Kowalewski2012Arylsulfatase).

The enzyme's active site includes a conserved aspartate residue at position 45, which is crucial for its enzymatic activity. This residue coordinates a calcium ion next to the catalytic formylglycine (FGly) residue, essential for all human sulfatases (Khateb2018A). ARSG is ubiquitously expressed in various tissues, including the kidney, testis, liver, spleen, brain, retina, and cochlea, indicating its broad role in cellular metabolism and maintenance (Velde2022Usher). Proper functioning of ARSG is vital for normal cellular metabolism and tissue homeostasis.

## Clinical Significance
Mutations in the ARSG gene are associated with Usher syndrome type IV, a condition characterized by late-onset retinitis pigmentosa (RP) and progressive sensorineural hearing loss (SNHL) without vestibular dysfunction. This syndrome is linked to specific ARSG variants that result in the loss of enzyme activity, leading to isolated retinal and cochlear defects (Velde2022Usher). The ARSG gene encodes a lysosomal sulfatase expressed in the retina and cochlea, and its dysfunction is associated with cellular degeneration in these tissues (Velde2022Usher).

Atypical Usher syndrome, also linked to ARSG mutations, presents with similar symptoms, including late-onset SNHL and RP, but without vestibular involvement. Specific variants, such as the homozygous missense variant p.D45Y, have been identified as causative, abolishing the enzymatic activity of ARSG and leading to these clinical manifestations (Khateb2018A; Fowler2021Multimodal).

In addition to Usher syndrome, ARSG variants have been implicated in task-specific dystonia, such as musician's dystonia and writer's cramp, suggesting a potential role in these conditions, although no conclusive mutation has been detected (Nibbeling2015Accumulation).


## References


[1. (Velde2022Usher) Hedwig M. Velde, Janine Reurink, Sebastian Held, Catherina H. Z. Li, Suzanne Yzer, Jaap Oostrik, Jack Weeda, Lonneke Haer-Wigman, Helger G. Yntema, Susanne Roosing, Laurenz Pauleikhoff, Clemens Lange, Laura Whelan, Adrian Dockery, Julia Zhu, David J. Keegan, G. Jane Farrar, Hannie Kremer, Cornelis P. Lanting, Markus Damme, and Ronald J. E. Pennings. Usher syndrome type iv: clinically and molecularly confirmed by novel arsg variants. Human Genetics, 141(11):1723–1738, February 2022. URL: http://dx.doi.org/10.1007/s00439-022-02441-0, doi:10.1007/s00439-022-02441-0. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-022-02441-0)

[2. (Khateb2018A) Samer Khateb, Björn Kowalewski, Nicola Bedoni, Markus Damme, Netta Pollack, Ann Saada, Alexey Obolensky, Tamar Ben-Yosef, Menachem Gross, Thomas Dierks, Eyal Banin, Carlo Rivolta, and Dror Sharon. A homozygous founder missense variant in arylsulfatase g abolishes its enzymatic activity causing atypical usher syndrome in humans. Genetics in Medicine, 20(9):1004–1012, September 2018. URL: http://dx.doi.org/10.1038/gim.2017.227, doi:10.1038/gim.2017.227. This article has 54 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/gim.2017.227)

[3. (Nibbeling2015Accumulation) Esther Nibbeling, Susen Schaake, Marina A. Tijssen, Anne Weissbach, Justus L. Groen, Eckart Altenmüller, Dineke S. Verbeek, and Katja Lohmann. Accumulation of rare variants in the arylsulfatase g (arsg) gene in task-specific dystonia. Journal of Neurology, 262(5):1340–1343, April 2015. URL: http://dx.doi.org/10.1007/s00415-015-7718-3, doi:10.1007/s00415-015-7718-3. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00415-015-7718-3)

[4. (Ferrante2002Molecular) Paola Ferrante, Silvia Messali, Germana Meroni, and Andrea Ballabio. Molecular and biochemical characterisation of a novel sulphatase gene: arylsulfatase g (arsg). European Journal of Human Genetics, 10(12):813–818, December 2002. URL: http://dx.doi.org/10.1038/sj.ejhg.5200887, doi:10.1038/sj.ejhg.5200887. This article has 43 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.ejhg.5200887)

[5. (Fowler2021Multimodal) Nicholas H. Fowler, May I. El-Rashedy, Emad A. Chishti, Craig W. Vander Kooi, and Ramiro S. Maldonado. Multimodal imaging and genetic findings in a case of arsg-related atypical usher syndrome. Ophthalmic Genetics, 42(3):338–343, February 2021. URL: http://dx.doi.org/10.1080/13816810.2021.1891552, doi:10.1080/13816810.2021.1891552. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/13816810.2021.1891552)

[6. (Kowalewski2012Arylsulfatase) Björn Kowalewski, William C. Lamanna, Roger Lawrence, Markus Damme, Stijn Stroobants, Michael Padva, Ina Kalus, Marc-André Frese, Torben Lübke, Renate Lüllmann-Rauch, Rudi D’Hooge, Jeffrey D. Esko, and Thomas Dierks. Arylsulfatase g inactivation causes loss of heparan sulfate 3- o -sulfatase activity and mucopolysaccharidosis in mice. Proceedings of the National Academy of Sciences, 109(26):10310–10315, June 2012. URL: http://dx.doi.org/10.1073/pnas.1202071109, doi:10.1073/pnas.1202071109. This article has 58 citations.](https://doi.org/10.1073/pnas.1202071109)